These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 860202)

  • 1. Adverse cardiodynamic effects of vasopressin not avoided by selective intra-arterial administration.
    Sirinek KR; Thomford NR; Pace WG
    Surgery; 1977 Jun; 81(6):723-8. PubMed ID: 860202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarity of arterial and intravenous vasopressin on portal and systemic hemodynamics.
    Barr JW; Lakin RC; Rösch J
    Gastroenterology; 1975 Jul; 69(1):13-9. PubMed ID: 1150017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative effects of selective intra-arterial and intravenous vasopressin infusion.
    Davis GB; Bookstein J; Hagan PL
    Radiology; 1976 Sep; 120(3):537-8. PubMed ID: 948583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of superior mesenteric artery vasopressin infusions on cardiac output and coronary blood flow in dogs.
    Fisher CH; Sheff RN; Novak G; White RI
    Invest Radiol; 1974; 9(6):456-61. PubMed ID: 4430585
    [No Abstract]   [Full Text] [Related]  

  • 5. Vasopressin: route of administration and effects on canine hepatic and superior mesenteric arterial blood flows.
    Kerr JC; Hobson RW; Seelig RF; Swan KG
    Ann Surg; 1978 Feb; 187(2):137-42. PubMed ID: 147062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoproterenol added during vasopressin administration provides cardiodynamic advantages.
    Sirinek KR; Martin EW; Thomford NR
    Rev Surg; 1976; 33(1):60-3. PubMed ID: 1246590
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of vasopressin on cardiac output and its distribution in the subhuman primate.
    Kerr JC; Jain KM; Swan KG; Rocko JM
    J Vasc Surg; 1985 May; 2(3):443-9. PubMed ID: 3999236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small bowel and liver pO2 during vasopressin infusion into the superior mesenteric artery.
    Korsbäck C; Höckerstedt K
    Ann Chir Gynaecol; 1984; 73(1):50-3. PubMed ID: 6732158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intravenous vasopressin on canine mesenteric arterial blood flow, bowel oxygen consumption, and cardiac output.
    Athanasoulis CA; Waltman AC; Simmons JT; Sheehan B; Coggins CH
    AJR Am J Roentgenol; 1978 Jun; 130(6):1033-9. PubMed ID: 418636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vertebral, carotid and intravenous infusions of lysine vasopressin on plasma vasopressin and cardiovascular function.
    Brooks DP; Share L; Crofton J; Matsui K; Rockhold RW
    Neuroendocrinology; 1984 Oct; 39(4):350-5. PubMed ID: 6493446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous versus superior mesenteric artery vasopressin infusions for the treatment of variceal bleeding.
    Burgener FA; Gutierrez OH
    Radiology; 1982 Mar; 142(3):769-72. PubMed ID: 6977790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of intra-arterial and intraportal injections of vasopressin on the simultaneously perfused hepatic arterial and portal venous vascular beds of the dog.
    Richardson PD; Withrington PG
    Circ Res; 1978 Oct; 43(4):496-503. PubMed ID: 688553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological vs. mechanical reduction in portal pressure: a comparative study.
    Groszmann RJ; Blei AT; Storer EH; Conn HO
    Surgery; 1978 Nov; 84(5):679-85. PubMed ID: 715683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primate mesenteric blood flow. Effects of vasopressin and its route of delivery.
    Freedman AR; Kerr JC; Swan KG; Hobson RW
    Gastroenterology; 1978 May; 74(5 Pt 1):875-8. PubMed ID: 416990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior mesenteric blood flow in man following injection of bradykinin and vasopressin into the superior mesenteric artery.
    Norryd C; Dencker H; Lunderquist A; Olin T
    Acta Chir Scand; 1975; 141(2):119-28. PubMed ID: 1098345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of superior mesenteric arterial and intravenous vasopressin infusions in patients with portal hypertension.
    Kaufman SL; Maddrey WC; Harrington DP; White RI
    Invest Radiol; 1977; 12(3):210-4. PubMed ID: 863624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal and systemic effects of selective infusion of vasopressin into the superior mesenteric artery in cirrhotic patients.
    Millette B; Huet PM; Lavoie P; Viallet A
    Gastroenterology; 1975 Jul; 69(1):6-12. PubMed ID: 1150036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous nitroglycerin to improve coronary blood flow and left ventricular performance during vasopressin therapy.
    Bush HL; Nabseth DC
    Surg Forum; 1979; 30():226-8. PubMed ID: 120016
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of vasopressin on hepatic arterial blood flow.
    Simmons JT; Baum S; Sheehan BA; Ring EJ; Athanasoulis CA; Waltman AC; Coggins PC
    Radiology; 1977 Sep; 124(3):637-40. PubMed ID: 887752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of isoproterenol prevents adverse hemodynamic effects of vasopressin.
    Skivolocki WP; Thomford NR
    Surgery; 1973 Nov; 74(5):752-7. PubMed ID: 4742759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.